Back In The Game: One Year After Rx Exit, P&G Signs On To Promote Silenor
This article was originally published in The Pink Sheet Daily
Executive Summary
Somaxon and P&G are preparing to launch the insomnia drug in September with a combined sales force of 215 reps.